Karolinska Development
Karolinska Development, renamed KDventures AB (Nasdaq Stockholm: KDV) in January 2026, is a Solna-based listed life-science investment company founded in 2003 that takes direct minority-to-majority equity stakes in Nordic biotech and medtech companies, several sourced from Karolinska Institutet research, and realises value through licensing deals, trade sales and IPOs.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
1 fund tracked, 8 portfolio companies (8 active · 0 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
8 companiesFunds & portfolio
Every fund Karolinska Development has raised, with its portfolio companies. Hand-checked from public filings.
Karolinska DevelopmentLife Sciences VCActive2003 · 23yr8 active
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech |  Sweden | 2021 | |
| Biotech |  US | 2003 | |
| Biotech | Sweden | 2004 | |
| Biotech |  Denmark | 2024 | |
| Biotech | Sweden | 2011 | |
| MedTech | Sweden | 2011 | |
| Biotech | Sweden | 2022 | |
| Biotech | Sweden | 2020 |
Sweden· Entry 2021US· Entry 2003Sweden· Entry 2004Denmark· Entry 2024Sweden· Entry 2011Sweden· Entry 2011Sweden· Entry 2022Sweden· Entry 2020Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on Karolinska Development.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in